Table 1 Systemic hemodynamics
| Â | Baseline (t0) | Endotoxemia (t1) | Resuscitation (t2) |
|---|---|---|---|
Mean arterial blood pressure (mmHg) | Â | Â | Â |
   Nonresuscitation group | 117 ± 6 | 105 ± 13†| 96 ± 19*†|
   HES130/0.4 (Voluven®) group | 118 ± 6 | 102 ± 21†| 96 ± 26*†|
   HES200/0.5 (HES-STERIL® 6%) group | 119 ± 9 | 105 ± 11†| 114 ± 14 |
   Ringer's lactate group | 113 ± 10 | 102 ± 18†| 123 ± 26 |
   Control group | 113 ± 4 | 127 ± 3* | 129 ± 6*‡ |
Heart rate (beats/minute) | Â | Â | Â |
   Nonresuscitation group | 263 ± 21 | 278 ± 27†| 294 ± 30*†|
   HES130/0.4 (Voluven®) group | 268 ± 25 | 277 ± 22†| 299 ± 24*†|
   HES200/0.5 (HES-STERIL® 6%) group | 252 ± 16 | 269 ± 27* | 295 ± 16*†|
   Ringer's lactate group | 247 ± 14 | 264 ± 26* | 280 ± 19*†|
   Control group | 261 ± 9 | 248 ± 9* | 256 ± 7‡ |
Central venous pressure (mmHg) | Â | Â | Â |
   Nonresuscitation group | 3.8 ± 1.3 | 3.9 ± 0.6 | 3.7 ± 0.8 |
   HES130/0.4 (Voluven®) group | 4.0 ± 0.9 | 4.0 ± 0.9 | 6.3 ± 1.2*†‡ |
   HES200/0.5 (HES-STERIL® 6%) group | 4.2 ± 0.6 | 3.9 ± 0.6 | 6.0 ± 1.5*‡ |
   Ringer's lactate group | 3.8 ± 0.9 | 4.0 ± 1.4 | 6.7 ± 1.7*†‡ |
   Control group | 4.2 ± 0.9 | 4.5 ± 1.8 | 4.6 ± 1.1 |
Renal blood flow (ml/minute) | Â | Â | Â |
   Nonresuscitation group | 4.9 ± 0.9 | 2.5 ± 1.1*†| 2.1 ± 1.3*†|
   HES130/0.4 (Voluven®) group | 4.8 ± 1.0 | 2.1 ± 0.9*†| 4.9 ± 1.5‡ |
   HES200/0.5 (HES-STERIL® 6%) group | 5.4 ± 1.0 | 2.0 ± 0.7*†| 6.7 ± 1.1*†‡ |
   Ringer's lactate group | 4.9 ± 0.9 | 3.0 ± 1.2*†| 5.7 ± 1.3*‡ |
   Control group | 5.6 ± 0.9 | 5.1 ± 1.0 | 5.1 ± 1.0‡ |
Renal vascular resistance (dyne/s/cm5) | Â | Â | Â |
   Nonresuscitation group | 26 ± 6 | 50 ± 22*†| 51 ± 22*†|
   HES130/0.4 (Voluven®) group | 25 ± 6 | 58 ± 32* | 21 ± 8‡ |
   HES200/0.5 (HES-STERIL® 6%) group | 23 ± 5 | 57 ± 22*†| 17 ± 1†‡ |
   Ringer's lactate group | 24 ± 7 | 38 ± 9*†| 21 ± 2†‡ |
   Control group | 21 ± 3 | 26 ± 5* | 26 ± 5*‡ |